Part D Off-Label Prescription Parity Act
Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.
Part D Off-Label Prescription Parity Act - Amends part D (Voluntary Prescription Drug Benefit Program) of title XVIII (Medicare) of the Social Security Act to permit a prescription drug plan (PDP) sponsor offering a PDP or a MedicareAdvantage (MA) organization offering an MA-PD plan to offer coverage of covered part D drugs for uses that are determined to be for medically accepted indications based upon: (1) guidance provided by the Secretary of Health and Human Services (HHS) for determining accepted uses of covered part D drugs; and (2) supportive clinical evidence in peer reviewed medical literature.
Referred to House Ways and Means
- Introduced in House Formatted Text PDF Formatted XML
Cite this page
U.S. Congress. (2026). H.R. 5732: Part D Off-Label Prescription Parity Act. 111th Congress. Open America. https://openamerica.io/bill/111-HR-5732/
"H.R. 5732: Part D Off-Label Prescription Parity Act." 111th Congress, 2026, Open America, https://openamerica.io/bill/111-HR-5732/.
H.R. 5732, 111th Cong. (2026), https://openamerica.io/bill/111-HR-5732/.
[H.R. 5732: Part D Off-Label Prescription Parity Act](https://openamerica.io/bill/111-HR-5732/)